Monthly pulses of methylprednisolone in SLE nephritis

M. R. Liebling, K. McLaughlin, S. Boonsue, J. Kasdin, E. V. Barnett

Research output: Contribution to journalArticle

36 Scopus citations

Abstract

The results of a double-blind trial of pulse methylprednisolone in 6 patients with systemic lupus erythematosus and biopsy proven diffuse proliferative glomerulonephritis are reviewed. Patients were given 1 g of methylprednisolone or placebo intravenously, on 3 consecutive days, once a month, for 1 year. After 1 year, the methylprednisolone pulse group showed a significant improvement in serum creatinine whereas the placebo group showed none. More than 2 years after completing the study, renal function remained stable in the methylprednisolone group while the placebo group demonstrated significant deterioration in these values. Because of the limited number of patients involved, a concurrent control group was employed to confirm these results.

Original languageEnglish (US)
Pages (from-to)543-548
Number of pages6
JournalJournal of Rheumatology
Volume9
Issue number4
StatePublished - Dec 1 1982

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Monthly pulses of methylprednisolone in SLE nephritis'. Together they form a unique fingerprint.

  • Cite this

    Liebling, M. R., McLaughlin, K., Boonsue, S., Kasdin, J., & Barnett, E. V. (1982). Monthly pulses of methylprednisolone in SLE nephritis. Journal of Rheumatology, 9(4), 543-548.